Features | Healtcare News | BioTuesdays by Kilmer Lucas IR

This Week's Feature

Dr. Doug Manion of Kleo Pharmaceuticals talks up new approach to treating multiple myeloma

Dr. Doug Manion As chairman and CEO of Kleo Pharmaceuticals, a private immuno-oncology company developing next-generation bispecific compounds designed to enhance the activity of biologics, Dr. Doug Manion has a...

April 7, 2020

Features

Amidst a global pandemic, two biotech companies offer innovative solutions

Since COVID-19 was first identified in China late last year, researchers have been working tirelessly to develop diagnostics, therapeutics and vaccines in an effort to prevent the spread of the SARS-CoV-2 virus. Many...

March 31, 2020

Features

Bee Vectoring bringing nature’s solution to healthy crops

Ashish Malik, CEO Using the natural pollination process of commercially-reared bees and biological products and controls, Bee Vectoring Technology International (TSXV, CVE:BEE; OTCQB:BEVVF) has developed a pest and...

March 24, 2020

Features

Obalon developing retail strategy for its weight loss solution: a swallowable, gas-filled intragastric balloon

Bill Plovanic, President and CEO Obalon Therapeutics (NASDAQ:OBLN) is pivoting its business model to a retail strategy of company-managed clinics to deliver its Obalon Balloon System, a weight loss solution that is the...

March 17, 2020

Features

Diabeloop bringing innovation to Type 1 diabetes patients

Marc Julien, Co-CEO Closely-held Diabeloop of Grenoble, France has developed an external Type 1 diabetes management system, known as DBLG1, that connects three components: a continuous glucose monitor, a patch-like...

March 10, 2020

Features

Anixa Biosciences harnessing interactions between tumors and the immune system

Amit Kumar, Chairman, President and CEO Anixa Biosciences (NASDAQ:ANIX) is taking multiple approaches to fighting cancer, developing both a diagnostic and therapeutics, such as a cancer immunotherapy and vaccine, to...

March 3, 2020

Features

Ocugen developing therapies for rare and underserved eye diseases

Shankar Musunuri, Chairman, CEO and Co-Founder Ocugen (NASDAQ:OCGN) is taking a multi-pronged approach to ophthalmology with a diversified pipeline that includes a breakthrough modifier gene therapy platform, novel...

February 25, 2020

Features

Genocea Biosciences: for the next generation of immunotherapies, targets matter

Chip Clark, President and CEO Using its unique ATLAS proprietary technology platform, Genocea Biosciences (NASDAQ:GNCA) is developing cancer immunotherapies that direct the body’s own tumor-fighting T-cells to the most...

February 18, 2020

Features

Ripple Therapeutics pursues financing for Phase 2 intravitreal implant trial and Epidel platform expansion

Tom Reeves, President and CEO Closely-held Ripple Therapeutics, a recent spinout from Interface Biologics, is pursuing a $25-million series A financing to complete a Phase 2 trial of IBE-814 IVT, a dexamethasone prodrug...

February 11, 2020

Features

Stereotaxis focused on next generation robotic innovation in interventional medicine

David Fischel, Chairman and CEO Stereotaxis’ (NYSE American: STXS) launch in June 2019 of a next generation surgical robotic system, Genesis RMN, solidifies its commitment to innovation and collaboration as a stepping...

February 4, 2020

Features

Inagene personalizing pain management with comprehensive genetic test

Nancy White, CEO Closely-held pharmacogenetics company, Inagene Diagnostics, aims to replace the “trial-and-error” approach to pain management with a comprehensive genetic test that helps physicians provide personalized...

January 28, 2020

Features

Liminal BioSciences making headway in strategic transformation

Kenneth Galbraith, CEO Liminal BioSciences (NASDAQ, TSX:LMNL) is undergoing a significant strategic transformation to simplify its operations, achieve financial stability and focus R&D on small molecule therapeutics...

January 21, 2020

Dr. Doug Manion of Kleo Pharmaceuticals talks up new approach to treating multiple myeloma

Amidst a global pandemic, two biotech companies offer innovative solutions

Bee Vectoring bringing nature’s solution to healthy crops

Obalon developing retail strategy for its weight loss solution: a swallowable, gas-filled intragastric balloon

Diabeloop bringing innovation to Type 1 diabetes patients

Anixa Biosciences harnessing interactions between tumors and the immune system

Ocugen developing therapies for rare and underserved eye diseases

Genocea Biosciences: for the next generation of immunotherapies, targets matter

Ripple Therapeutics pursues financing for Phase 2 intravitreal implant trial and Epidel platform expansion

Stereotaxis focused on next generation robotic innovation in interventional medicine

Inagene personalizing pain management with comprehensive genetic test

Liminal BioSciences making headway in strategic transformation

Follow Us

General

More